SCHEMBL4856576

SCHEMBL4856576

Cc1ccccc1-c1ccc(OCCCCCN2CCCC2)c(C=O)c1

nearest known ligand 0.52

Predicted protein targets (top 20)

geneUniProtsupporting neighboursconfidence
CYP2D6 P10635 2/20 0.52
CYP2C19 P33261 2/20 0.52
ALDH1A1 P00352 6/20 0.49
KDM4E B2RXH2 4/20 0.49
KMT2A Q03164 4/20 0.49
MEN1 O00255 3/20 0.49
LMNA P02545 1/20 0.49
TP53 P04637 1/20 0.49
POLB P06746 1/20 0.49
RECQL P46063 1/20 0.49
RAD52 P43351 1/20 0.48
L3MBTL1 Q9Y468 1/20 0.48
CYP1A2 P05177 1/20 0.47
CYP3A4 P08684 1/20 0.47
CYP2C9 P11712 1/20 0.47
TDP1 Q9NUW8 1/20 0.47
SMYD2 Q9NRG4 1/20 0.47
HRH3 Q9Y5N1 3/20 0.46
KCNH2 Q12809 1/20 0.46
HRH4 Q9H3N8 1/20 0.46

Click a target to see other patent compounds predicted against it — the reverse direction, in place.

Similar compounds — the chemically nearest patent molecules

Nearest neighbours by Morgan-fingerprint cosine across the patent-compound collection, with each neighbour's top predicted target and the predicted targets it shares with this molecule.

Compoundsimilaritytop predictedshared targets
SCHEMBL4849189 0.99 CYP2D6 (0.53) CYP2D6CYP2C19ALDH1A1KDM4EKMT2A
SCHEMBL4854885 0.92 TDP1 (0.56) CYP2D6CYP2C19ALDH1A1KDM4EKMT2A
SCHEMBL4854976 0.78 CYP1A2 (0.47) CYP2D6CYP2C19ALDH1A1KDM4EKMT2A
SCHEMBL4855017 0.78 KDM4E (0.49) ALDH1A1KDM4EKMT2AMEN1
SCHEMBL4847720 0.78 BACE1 (0.51) ALDH1A1KDM4EKMT2AMEN1LMNA
SCHEMBL10679697 0.78 HRH3 (0.68) HRH3KCNH2HRH4
SCHEMBL11022798 0.77 CYP2D6 (0.71) CYP2D6CYP2C19ALDH1A1KDM4EKMT2A
SCHEMBL10679192 0.77 HRH3 (0.69) ALDH1A1KDM4EL3MBTL1HRH3KCNH2
SCHEMBL4852186 0.77 SLC6A9 (0.46) CYP2D6CYP2C19ALDH1A1KDM4EKMT2A
SCHEMBL4854149 0.77 BACE1 (0.52) ALDH1A1KDM4EKMT2AMEN1LMNA

Similarity is cosine over the 2,048-bit Morgan fingerprint (≈ Tanimoto). Identical fingerprints score 1.00.

Patent provenance — the patents this molecule appears in, and who filed them

Claimed or disclosed in 2 patents. claimed = in the patent's claims; disclosed = body only.

PatentTitleAssigneePublishedPriorityFilingCountryStatus
US-7423181-B2 in particular against bacterial and parasitic infections, fungi, and helminths; improved metabolic and physiochemical properties, bioavailability, solubility; 3-[4-(2-Dimethylamino-ethoxy)-2'-trifluoromethyl-biphenyl-3-yl]-1-(2-dimethylaminomethyl-phenyl)-propenone LICA PHARMACEUTICALS A/S (DK) 2008-09-09 US disclosed
US-20050227990-A1 Aminoalkoxy-functional chalcones LICA PHARMACEUTICALS A/S (DK) 2005-10-13 US disclosed